Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |